Is antipsychotic medication stigmatizing for people with mental illness?

被引:37
作者
Sajatovic, Martha [1 ]
Jenkins, Janis H. [1 ]
机构
[1] Case Western Reserve Univ, Sch Med, Cleveland, OH 44106 USA
关键词
D O I
10.1080/09540260701278911
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Antipsychotic medications are clearly identified as important in the treatment of individuals with schizophrenia and with bipolar disorder. However, negative societal reaction related to having a serious mental illness and the socially undesirable side effects associated with antipsychotic medication treatment may combine to worsen stigma associated with treatment for mental illness. Specific stigmatizing effects of antipsychotic therapy may be difficult to evaluate independently from factors such as symptoms, insight into illness and side effects. Attitudes towards antipsychotic medication may be positive in individuals who recognize therapeutic drug effects, however other individuals may view medications negatively due to a sense of stigma. Stigma among individuals with bipolar disorder in relation to treatment with antipsychotic medication has not been well addressed in the literature. An additional concern among individuals with bipolar disorder who receive antipsychotic medications may be the notion that antipsychotics are 'schizophrenia drugs', and thus an inappropriate treatment for their condition. Antipsychotic medications can be stigmatizing for patients with serious mental illness, however the roots of stigma are extensive, and efforts to minimize stigma can only be successful when addressed by the individual with illness, their families and loved ones, treatment providers and society at large.
引用
收藏
页码:107 / 112
页数:6
相关论文
共 31 条
[2]  
[Anonymous], 2002, PRACT GUID TREATM PA
[3]   Assessment of the patient's subjective experience in acute neuroleptic treatment: Implications for compliance and outcome [J].
Awad, AG ;
Voruganti, LNP ;
Heslegrave, RJ ;
Hogan, TP .
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1996, 11 :55-59
[4]   SUBJECTIVE RESPONSE TO NEUROLEPTICS IN SCHIZOPHRENIA [J].
AWAD, AG .
SCHIZOPHRENIA BULLETIN, 1993, 19 (03) :609-618
[5]   Is low self-esteem an inevitable consequence of stigma? An example from women with chronic mental health problems [J].
Camp, DL ;
Finlay, WML ;
Lyons, E .
SOCIAL SCIENCE & MEDICINE, 2002, 55 (05) :823-834
[6]   The quest for well-being: A qualitative study of the experience of taking antipsychotic medication [J].
Carrick, R ;
Mitchell, A ;
Powell, RA ;
Lloyd, K .
PSYCHOLOGY AND PSYCHOTHERAPY-THEORY RESEARCH AND PRACTICE, 2004, 77 :19-33
[7]   Toward convergence in the medication treatment of bipolar disorder and schizophrenia [J].
Citrome, L ;
Goldberg, JF ;
Stahl, SM .
HARVARD REVIEW OF PSYCHIATRY, 2005, 13 (01) :28-42
[8]   CAN CLIENTS WITH SCHIZOPHRENIA DESCRIBE FEELINGS AND BELIEFS ABOUT TAKING MEDICATION [J].
DAVIDHIZAR, RE .
JOURNAL OF ADVANCED NURSING, 1985, 10 (05) :469-473
[9]   Attitudes of schizophrenia outpatients toward psychiatric medications: Relationship to clinical variables and insight [J].
Freudenreich, O ;
Cather, C ;
Evins, AE ;
Henderson, DC ;
Goff, DC .
JOURNAL OF CLINICAL PSYCHIATRY, 2004, 65 (10) :1372-1376
[10]   Schizophrenia practice guidelines: international survey and comparison [J].
Gaebel, W ;
Weinmann, S ;
Sartorius, N ;
Rutz, W ;
McIntyre, JS .
BRITISH JOURNAL OF PSYCHIATRY, 2005, 187 :248-255